Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Post by stock_itchon Oct 03, 2014 9:55pm

207 Views

Post# 22998267

Price back down to Pre-ABSORICA US release - Pros loading up

I didn't expect to be able to get more shares under $12 after that lastest press release so happy the price retraced. This product is building a good rap with acme prone teenagers as from what I am reading it's the best solution. All the comments stated that the only common side effects are dry lips and skin.

Bullboard Posts

This junior mining stock offers billions in market exposure